P2Y receptors and atherosclerosis in apolipoprotein E-deficient mice

被引:37
|
作者
Guns, Pieter-Jan D. F. [1 ]
Hendrickx, Jan [1 ]
Van Assche, Tim [1 ]
Fransen, Paul [1 ]
Bult, Hidde [1 ]
机构
[1] Univ Antwerp, CDE, Div Pharmacol, B-2610 Antwerp, Belgium
关键词
atherosclerosis; apoE; P2Y(6); P2Y(2); gene expression; macrophage; suramin; PPADS; SMOOTH-MUSCLE-CELLS; DOUBLE-KNOCKOUT MICE; ENDOTHELIAL-CELLS; NUCLEOTIDE RECEPTORS; EXPRESSION; SURAMIN; GROWTH; MOUSE; UDP; LIPOPOLYSACCHARIDE;
D O I
10.1111/j.1476-5381.2009.00497.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background and purpose: P2Y nucleotide receptors are involved in the regulation of vascular tone, smooth muscle cell (SMC) proliferation and inflammatory responses. The present study investigated whether they are involved in atherosclerosis. Experimental approach: mRNA of P2Y receptors was quantified (RT-PCR) in atherosclerotic and plaque-free aorta segments of apolipoprotein E-deficient (apoE(-/-)) mice. Macrophage activation was assessed in J774 macrophages, and effects of non-selective purinoceptor antagonists on atherosclerosis were evaluated in cholesterol-fed apoE(-/-) mice. Key results: P2Y(6) receptor mRNA was consistently elevated in segments with atherosclerosis, whereas P2Y(2) receptor expression remained unchanged. Expression of P2Y(1) or P2Y(4) receptor mRNA was low or undetectable, and not influenced by atherosclerosis. P2Y(6) mRNA expression was higher in cultured J774 macrophages than in cultured aortic SMCs. Furthermore, immunohistochemical staining of plaques demonstrated P2Y(6)-positive macrophages, but few SMCs, suggesting that macrophage recruitment accounted for the increase in P2Y(6) receptor mRNA during atherosclerosis. In contrast to ATP, the P2Y(6)-selective agonist UDP increased mRNA expression and activity of inducible nitric oxide synthase and interleukin-6 in J774 macrophages; this effect was blocked by suramin (100-300 mu M) or pyridoxal-phosphate-6-azophenyl-2'-4'-disulphonic acid (PPADS, 10-30 mu M). Finally, 4-week treatment of cholesterol-fed apoE(-/-) mice with suramin or PPADS (50 and 25 mg.kg(-1).day(-1) respectively) reduced plaque size, without changing plaque composition (relative SMC and macrophage content) or cell replication. Conclusions and implications: These results suggest involvement of nucleotide receptors, particularly P2Y(6) receptors, during atherosclerosis, and warrant further research with selective purinoceptor antagonists or P2Y(6) receptor-deficient mice. British Journal of Pharmacology (2010) 159, 326-336; doi: 10.1111/j.1476-5381.2009.00497.x; published online 24 December 2009
引用
收藏
页码:326 / 336
页数:11
相关论文
共 50 条
  • [21] Humoral immunity accelerates atherosclerosis in apolipoprotein E-deficient mice.
    Dansky, HM
    Barlow, CB
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (04) : 713 - 713
  • [22] ASSOCIATION IN EARLY ATHEROSCLEROSIS WITH RENAL FIBROSIS IN APOLIPOPROTEIN E-DEFICIENT MICE
    Tonini, G.
    de Paiva, V. Nunes
    Camara, N.
    Gidlund, M.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [23] Decorin overexpression reduces the development of atherosclerosis in apolipoprotein E-deficient mice
    Zen, AAH
    Caligiuri, G
    Sainz, JM
    Lemitre, M
    de Chappedelaine, C
    Lafont, A
    CIRCULATION, 2004, 110 (17) : 82 - 82
  • [24] Vessel transplantation of apolipoprotein E-deficient mice as a model of atherosclerosis regression
    Tonar, Z
    Bobkova, D
    Havlickova, J
    Poledne, R
    ATHEROSCLEROSIS SUPPLEMENTS, 2005, 6 (01) : 45 - 45
  • [25] Decorin overexpression reduces atherosclerosis development in apolipoprotein E-deficient mice
    Al Haj Zen, Ayman
    Caligiuri, Giuseppina
    Sainz, Julie
    Lemitre, Mathilde
    Demerens, Corinne
    Lafont, Antoine
    ATHEROSCLEROSIS, 2006, 187 (01) : 31 - 39
  • [26] Mast Cell Deficiency Attenuates Atherosclerosis in Apolipoprotein E-deficient mice
    Smith, Donald D.
    Tan, Xiaoyu
    Tawfik, Ossama
    Stechschulte, Daniel J.
    Dileepan, Kottarappat N.
    FASEB JOURNAL, 2008, 22
  • [27] The continuous administration of aspirin attenuates atherosclerosis in apolipoprotein E-deficient mice
    Paul, A
    Calleja, L
    Camps, J
    Osada, J
    Vilella, E
    Ferré, NL
    Mayayo, E
    Joven, J
    LIFE SCIENCES, 2000, 68 (04) : 457 - 465
  • [28] Proteomic profiling in apolipoprotein E-deficient mice during atherosclerosis progression
    Dursun, Evrim
    Ozben, Beste
    Monari, Emanuela
    Cuoghi, Aurora
    Tomasi, Aldo
    Ozben, Tomris
    ACTA HISTOCHEMICA, 2010, 112 (02) : 178 - 188
  • [29] Mulberry leaf powder prevents atherosclerosis in apolipoprotein E-deficient mice
    Harauma, Akiko
    Murayama, Toshinori
    Ikeyama, Kazuyuki
    Sano, Hideto
    Arai, Hidenori
    Takano, Ryo
    Kita, Toru
    Hara, Saburo
    Kamei, Kaeko
    Yokode, Masayuki
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2007, 358 (03) : 751 - 756
  • [30] Recombinant leptin promotes atherosclerosis and thrombosis in apolipoprotein E-deficient mice
    Bodary, PF
    Gu, SF
    Shen, YC
    Hasty, AH
    Buckler, JM
    Eitzman, DT
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (08) : 119 - 122